Scope Health recalls

FDA enforcement reports naming SCOPE HEALTH as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: May 6, 2026

Severity

May 6, 2026Optase Dry Eye Intense Drops (Glycerin 0Drug · SCOPE HEALTHLack of Assurance of SterilityClass II